Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion.
Saved in:
| Title: | Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion. |
|---|---|
| Authors: | Chan EY; Department of Paediatrics, Faculty of Medicine, The Chinese University of Hong Kong, Shatin, Hong Kong SAR. eugene.chan@cuhk.edu.hk.; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR. eugene.chan@cuhk.edu.hk., Lin KY; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR., Yap DY; Division of Nephrology, Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Hong Kong, Hong Kong SAR., Ma AL; Paediatric Nephrology Centre, Hong Kong Children's Hospital, Kowloon, Hong Kong SAR. |
| Source: | Pediatric nephrology (Berlin, Germany) [Pediatr Nephrol] 2025 Mar; Vol. 40 (3), pp. 711-714. Date of Electronic Publication: 2024 Oct 28. |
| Publication Type: | Journal Article; Case Reports |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 8708728 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-198X (Electronic) Linking ISSN: 0931041X NLM ISO Abbreviation: Pediatr Nephrol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1432-198X |
|---|---|
| DOI: | 10.1007/s00467-024-06570-8 |
